The four national paediatric cancer clinical trials organisations in the United States—the
Children's Cancer Group, the National Wilms' Tumor Study Group, the Intergroup …

The sequential outcome was evaluated for all childhood cancers in which the Pediatric
Oncology Group has conducted a series of clinical trials, with constant eligibility, on patients …

The Children's Oncology Group (COG) recently celebrated the milestone of 50 years of
pediatric clinical trials and collaborative research in oncology. Our group had its origins in …

BACKGROUND After injuries, cancer is the leading cause of death in children younger than
15 years in the United States. Despite dramatic increases in 5‐year survival rates, more than …

Cancer is still the chief cause of death by disease in children, ages one to 14. As improved
survival rates have been reported for pediatric cancer patients who are treated on controlled …

Clinical trials in paediatric cancer continue to be a key factor in progress toward better
treatment and prognosis. Paediatricians and family physicians may be asked by patients …

PURPOSE.: To determine whether adolescents with cancer, who in comparison to younger
patients have a higher cancer incidence and lower mortality reduction, have equal access to …

Multidisciplinary collaboration in therapeutic research in childhood cancer has been
responsible for enormous improvements in outcomes. Many of the improvements have …

F ROM THE BEGINNING of the modem cancer therapy era after World War II, the courses of
pediatric and adult cancers have diverged widely in cancer survival and in the system of …

Solid tumors account for approximately 70% of malignant neoplasms in children younger
than 15 years of age. The 5‐year survival of children with solid tumors increased from 27 …